About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, October 14th, 2015

The QualityStocks
Daily Stock List


Propanc Health Group Corp. (PPCH)

PennyStocks24, Greenbackers, PennyStockRumors.net, PricelessPennyStocks and Top Stock Picks reported on Propanc Health Group Corp. (PPCH), and we choose to report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Propanc Health Group Corp. is an emerging healthcare company. It is focusing on the development of new and proprietary treatments for cancer patients, especially those suffering from pancreatic and colorectal cancer. Propanc has developed - together with its scientific and oncology consultants - a rational, composite formulation of anti-cancer compounds that enable and support a variety of cancer treatment options. A development stage healthcare enterprise, Propanc Health Group is headquartered in Melbourne, Australia.

Its leading products are variations upon its novel formulation and involve or employ proenzymes. These are inactive precursors of enzymes. Propanc’s plan in the near term is to target patients with limited remaining therapeutic options for the treatment of solid tumors, including colorectal or pancreatic tumors. In the future, its plan is to develop its lead product to treat early stage cancer, pre-cancerous diseases and as a preventative measure for patients at risk of developing cancer based on genetic screening.  

Propanc announced in 2014 that it made major progress in connection with its continuing efforts to secure acceptance and approval of patent applications filed internationally. Its leading products are PRP and PRP-DCM. These are novel, patented suppository formulations based on proteolytic proenzymes, which are inactive precursors of enzymes.

PRP is a novel, patented, once daily suppository formulation of proteolytic proenzymes. Regarding PRP-DCM, recent work undertaken by Propanc has centered on maximizing the potential of PRP as a drug suitable for long term maintenance. Scientific research has focused on developing a novel combination of anti-cancer agents working in combination with proteolytic proenzymes that enhance PRP’s anti-cancer effects.

There are many preclinical activities underway for its lead product, PRP. Animal efficacy studies in a number of tumor cell lines are underway for PRP with Propanc’s research partner, vivoPharm, in Hershey, Pennsylvania. Moreover, it has chosen pancreatic cancer as its lead indication for human studies. With the background development history of PRP, its uniqueness as a potential treatment for pancreatic cancer, and the size of the target patient population for pancreatic cancer, Company Management will seek Orphan Drug Designation for PRP for this indication in each jurisdiction.

Propanc Health Group Corp. (PPCH), closed Wednesday's trading session at $0.0413, up 0.73%, on 1,707,151 volume with 82 trades. The average volume for the last 60 days is 4,306,903 and the stock's 52-week low/high is $0.001/$0.1338.

Smack Sportswear, Inc. (SMAK)

OTCJournal, Pumps and Dumps, StockMarketQuote.us, and The Green Baron reported earlier on Smack Sportswear, Inc. (SMAK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Smack Sportswear, Inc.’s commitment is to becoming a leading brand and service provider to the indoor and sand volleyball markets. The Company is a leading brand of custom apparel – mainly centered on the sport of volleyball. Olympians and top professionals design and test many of Smack Sportswear’s garments. Smack Sportswear was established out of a passion for volleyball on the sand of Manhattan Beach, California.

Founded in 1994, Smack Sportswear is headquartered in Torrance, California. The Company’s shares trade on the OTC Bulletin Board. Smack’s management team has more than 45 years of experience in the team sports apparel market.

Smack Sportswear’s designs are of a style that mirrors the personality of Southern California. Its designs blend comfortable fabrics with performance features that enable a functional fit. Smack offers styles to meet the needs of any club or team. For women and men, Smack Sportswear offers sublimated jerseys, core jerseys, bottoms, warm-ups, and also sand uniforms.

In Accessories, the Company offers socks, kneepads, and ankle braces. Moreover, it offers backpacks and bags. In Team Apparel, Smack offers tees, fleece, and coaches’ apparel. Furthermore, Smack Sportswear is planning to launch an online uniform builder. This will allow teams to design and order their custom uniforms online.

Mr. Bill Sigler founded Smack Sportswear in Manhattan Beach, California in 1994. He was the Company’s Chief Executive Officer since its establishment. He remains as a Board member. He is partnering with Smack Sportswear - as an independent distributor - to the hundreds of clubs and schools he has personally serviced over the last twenty years.

Many of Smack Sportswear’s styles and products have been inspired and tested by some of the foremost U.S. players. The Company’s lifestyle apparel was earlier featured on ABC’s popular show ‘The Bachelor”.

Smack Sportswear has its Ambassadors initiative. The aim of its Brand Ambassador Program is to develop a special relationship with fans of its brand and the lifestyle Smack embodies.  This involves testing new products and providing valuable feedback. Another aim is to convey the Southern California, Smack lifestyle message to others worldwide through grass roots promotions, activism and networking.

Smack Sportswear, Inc. (SMAK), closed Wednesday's trading session at $0.038, up 15.15%, on 157,551 volume with 8 trades. The average volume for the last 60 days is 67,195 and the stock's 52-week low/high is $0.02/$0.255.

OxySure Systems, Inc. (OXYS)

TaglichBrothers, PennyStocks24, RedChip, SmallCapGrowth, StockRunway, KingPennyStocks, Jet-Life Penny Stocks, Equity Observer, Wallstreet Profiler, Daily Stock Motion, Penny Pick Insider, PennyDoctor, and Penny Stocks VIP reported recently on OxySure Systems, Inc. (OXYS), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

OxySure Systems, Inc. is a global leader and medical device innovator of life-saving, user-friendly emergency oxygen solutions with its "oxygen from powder" technology. OxySure focuses on the design, manufacture, and distribution of specialty respiratory and medical solutions. It pioneered a safe and easy-to-use solution to produce medically pure (USP) oxygen from inert powders. A medical technology company, OxySure Systems has its corporate headquarters in Frisco, Texas.

OxySure owns many issued patents and patents pending on the above-mentioned technology. This technology makes the provision of emergency oxygen safer, more accessible, and easier to use than traditional oxygen provision systems. OxySure’s products improve access to emergency oxygen, which affects the survival, recovery, and safety of individuals in many areas of need.

The proprietary process and methodology is for the emergency/short duration oxygen supply market. With this technology, oxygen is generated on demand and there is no storage of oxygen. In addition, there are no compressed tanks, dials, valves, or regulatory maintenance. Moreover, there is no hydrostatic testing, no batteries, no required training, and none of the hazards associated with traditional oxygen provision systems.

OxySure’s launch product using this technology is the OxySure Model 615. This is a portable emergency oxygen device for lay person use. Model 615 bridges the gap between the beginning of a medical emergency and the time first responders arrive on the scene.

In addition to oxygen products for public/lay responder usage, OxySure Systems also markets emergency medical solutions. These include AEDs (Cardiac Science, Philips, Zoll, Physio Control, Defibtech, and HeartSine), Quickclot Bleeding Control solutions, resuscitation products, as well as pulse oximetry products.

This month, the Company announced that it appointed Mr. Christopher Kaplan to its Strategic Advisory Board. Mr. Kaplan is currently President of Cajetan, LLC. Cajetan is an independent healthcare consulting firm working with companies to deliver better value for patients, fuel innovation, enhance the impact and execution of marketing and sales initiatives, and reduce the cost and complexity of operating systems.

OxySure Systems, Inc. (OXYS), closed Wednesday's trading session at $0.27, down 3.57%, on 170,242 volume with 62 trades. The average volume for the last 60 days is 106,895 and the stock's 52-week low/high is $0.2088/$1.40.

PharmaCyte Biotech, Inc. (PMCB)

OTCJournal, Goldman Small Cap Research, SmallCapVoice, SmallCapNetwork, BUYINS.NET, Cannabis Financial Network News, and MyBestStockAlerts reported recently on PharmaCyte Biotech, Inc. (PMCB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company that centers on developing targeted treatments for cancer and diabetes utilizing its signature live cell encapsulation technology, Cell-in-a-Box®. This innovative and patented technology is being used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. OTCQB-listed, PharmaCyte Biotech is based in Silver Spring, Maryland.

PharmaCyte is also working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other types of solid cancerous tumors. The Company is ready to head into Phase 2b clinical trials in advanced inoperable pancreatic cancer in Australia. Its treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells that convert ifosfamide into its active or "cancer-killing" form. These capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer.

PharmaCyte Biotech is also developing treatments for cancer founded upon chemical constituents of the Cannabis plant, called cannabinoids. It is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects normally associated with cancer treatments.

The live-cell encapsulation technology that PharmaCyte employs is a way to enclose living cells in protective “cocoons” around the size of the head of a pin. PharmaCyte encapsulates living cells, not drugs.  Each capsule can enclose roughly 10,000 cells. This number can vary depending upon the size of the cells encapsulated.

PharmaCyte Biotech made headlines in the diabetes industry after a study was published that stated its Melligen cell line could produce insulin in diabetic mice. The Company has the exclusive worldwide rights to use the Melligen cells to treat diabetes.

Today, PharmaCyte Biotech announced that its upcoming clinical trial will determine whether its pancreatic cancer treatment (Cell-in-a-Box® capsules + low-doses of ifosfamide) can satisfy a critical unmet medical need for patients with pancreatic cancer when the “gold standard” treatment is no longer effective at treating the disease. At present, there is no adequate alternative treatment available.

PharmaCyte Biotech, Inc. (PMCB), closed Wednesday's trading session at $0.1225, up 5.79%, on 4,465,794 volume with 517 trades. The average volume for the last 60 days is 1,651,427 and the stock's 52-week low/high is $0.069/$0.27.

General Cannabis Corp. (CANN)

TopPennyStockMovers, Money Morning, SmallCapVoice, OTC Markets Group, and The Street reported earlier on General Cannabis Corp. (CANN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

General Cannabis Corp. is a service provider to businesses in the regulated cannabis industry. The Company’s mission is to lead the regulated cannabis industry by being a trusted partner to the cultivation and retail side of the cannabis business. A synergistic holding company, it formerly went by the name Advanced Cannabis Solutions, Inc. It changed its name to General Cannabis Corp. in June 2015. Founded in 2013, General Cannabis is based in Denver, Colorado.

The Company leases grow and related facilities (commercial real estate and equipment) to licensed business operators for their production requirements. The team from Next Big Crop Consulting has joined General Cannabis This gives the Company professional Consulting Platform Development Skills.

Furthermore, through its Iron Protection Group, combat veterans provide security services suited to the cannabis industry. This includes armed guards, training, in addition to secure transport services.

Moreover, General Cannabis is pursuing supplementary business products and services. These include customized finance, capital formation, banking, regulatory compliance consulting, security and advanced logistical support for grow operations.

The Company has strong operating divisions including real estate, consulting, security, and financing. It also distributes important infrastructure products to grow facilities and dispensaries. General Cannabis will continue to integrate partner companies. This is to provide a full complement of capabilities for its customers as the regulated cannabis industry continues to increase.

General Cannabis earlier was selected by The Marijuana Index for inclusion in its MJIC US Reporting Index. The Marijuana Index is the leading equity-tracking index featuring public companies engaged in the legalized marijuana and hemp sector. The MJIC Marijuana Index is the first and only Marijuana Sector Benchmark Index Series, measuring the combined performance of globally listed marijuana stocks.

Recently, General Cannabis announced that it entered into a Letter of Intent (LOI) to acquire casual lifestyle brand Chiefton Supply® from owners and founders Mr. Jacob Kulchin and Mr. Bryan DeHaven.  Crafted and curated in Denver, Colorado, Chiefton Supply offers a fresh alternative to the classic marijuana T-shirt. Chiefton makes street wear apparel and accessories for men and women.

General Cannabis Corp. (CANN), closed Wednesday's trading session at $1.04, up 1.96%, on 11,242 volume with 19 trades. The average volume for the last 60 days is 32,598 and the stock's 52-week low/high is $0.67/$9.50.


The QualityStocks
Company Corner


Galenfeha, Inc. (GLFH)

The QualityStocks Daily Newsletter would like to spotlight Galenfeha, Inc. (GLFH). Today, Galenfeha, Inc. closed trading at $0.23, up 4.50%, on 75,511 volume with 15 trades. The stock’s average daily volume over the past 60 days is 59,685, and its 52-week low/high is $0.1011/$4.00.

Galenfeha, Inc. is steadily gaining market acceptance with its stored energy solutions. The company's advancements in the industry are positioning Galenfeha to become the nation's leader in LiFePO4 chemistry usage. Patricia Delgado, President/CEO of Headway Headquarters, LLC commented, "Galenfeha is rapidly becoming one of our largest customers. Currently, there is only one company in the U.S. that utilizes this chemistry in a larger capacity, and Galenfeha is closing that gap."

Galenfeha, Inc. (GLFH) is an engineering, product development, and manufacturing company that provides innovative solutions for oil and natural gas production, as well as stored energy products across a number of different industries. The company provides these products and services through its stored energy and oil & gas division.

Through its stored energy division, Galenfeha offers one of the most powerful, environmentally friendly battery systems in the market. The batteries have onboard computers, are inherently safe, internally temperature regulated, have optional GPS monitoring capabilities, offer significant weight reduction of up to 50%, and are engineered specifically for each type of application. Features include 100% “green” chemistry, RoHS compliancy, and active short circuit protection control.

Through its oil and gas division, the company offers chemical injection pumps that merge the perceived benefits of a hybrid, electric over pneumatic system. Galenfeha management believes the combination of the two parameter control systems represents a measurable shift in efficiency, reliability, cost management, and profitability to individual well locations as well as entire production fields. The combined technologies have demonstrated increased chemical injection accuracy, reducing chemical contamination in the production process while controlling cost and waste.

The company’s unwavering dedication is to continuously develop products that perform better than conventional solutions while also reducing environmental impact. Leveraging the management team’s wealth of resources and relationships, Galenfeha is well positioned for continued growth as the company aims to expand in both the stored energy and oil & gas industries. Disclaimer

Galenfeha, Inc. Company Blog

Galenfeha, Inc. News:

Galenfeha On Track To Become Largest Consumer Of LiFePO4 Chemistry In U.S.

Galenfeha Secures Exclusive Distributor Agreement

Galenfeha Introduces iWaV Control System Innovation

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $3.94, up 2.34%, on 5,673 volume with 18 trades. The stock’s average daily volume over the past 60 days is 5,701, and its 52-week low/high is $1.25/$18.15.

International Stem Cell Corp. announced today that the Company will make an oral presentation on the comprehensive results of its preclinical development of human parthenogenetic neural stem cells (hPNSCs) for the treatment of Parkinson's Disease at Neuroscience 2015 in Chicago. "The comprehensive data collected from our extensive GLP studies serve as proof of safety and efficacy for our planned clinical trial for the treatment of Parkinson's Disease in Australia. We look forward to providing an update on the status of our regulatory submission to the Australian government in the near future," said Russell A. Kern, Ph.D. chief scientific officer of ISCO.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Presents Comprehensive Findings for Parkinson's Disease Program Preclinical Studies at the Society for Neuroscience Annual Meeting, Neuroscience 2015

International Stem Cell Corporation Develops Technology to Replace Cartilage for the Treatment of Osteoarthritis

International Stem Cell Names Ms. Ebrahimi as Chief Financial Officer

Fresh Promise Foods, Inc. (FPFI)

The QualityStocks Daily Newsletter would like to spotlight Fresh Promise Foods, Inc. (FPFI). Today, Fresh Promise Foods, Inc. closed trading at $0.0002, up 100.00%, on 2,000,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 15,388,621, and its 52-week low/high is $0.0001/$0.165.

Fresh Promise Foods, Inc. (FPFI) is a consumer products and marketing company operating in the high-margin multi-billion dollar health and wellness food and beverage sectors. The company sets itself apart from the competition by marrying innovative technology and product development with perceptive marketing and sales service strategy.

Through wholly-owned subsidiary Harvest Soul, Inc., FPFI produces the world's first USDA organic, Non-GMO Project verified chewable juice products. Utilizing some of the world's healthiest ingredients, the company creates a nutritionally-dense combination of fiber-rich vegetables and fruits mixed with tasty bits of chewable seeds, nuts and berries. By encouraging chewing during consumption, these revolutionary juices have been shown to jumpstart digestion and promote improved nutrient absorption.

Since launching its chewable juice products online in December 2014, the company has made considerable progress in expanding upon its market presence. As of its latest update, FPFI had secured placement in all 32 Whole Foods Market locations in its five-state southern region and entered into a distribution agreement with San Francisco-based Optimum Sales in order to expand its distribution footprint to include the West Coast and Pacific Northwest.

According to a report by the Organic Trade Association, sales of organic food and non-food products in the United States exceeded $39 billion in 2014, representing an increase of 11.3 percent over the previous year. As FPFI continues to expand its national distribution network, the company should be in a strong strategic position to leverage this market performance in order to promote sustainable growth.

FPFI is also committed to expanding its presence in the organic foods industry by investing in businesses that have identified a unique niche in the health and wellness sector. Through its ventures and emerging brands segment, the company looks to provide senior management support to pre-revenue or early-stage firms with an established leadership team and a passion for food, health and wellness. Disclaimer

Fresh Promise Foods, Inc. Company Blog

Fresh Promise Foods, Inc. News:

Fresh Promise Foods' Harvest Soul Division Launches New Organic GMO-Free Blended Juice Line, Procures Largest Purchase Order to Date

Fresh Promise Foods' Harvest Soul to Unveil Two New Organic Chewable Juice Flavors at Natural Products Expo East 2015

Fresh Promise Foods, Inc. (FPFI) CEO Featured in Exclusive QualityStocks Interview

Neah Power Systems, Inc. (NPWZ)

The QualityStocks Daily Newsletter would like to spotlight Neah Power Systems, Inc. (NPWZ). Today, Neah Power Systems, Inc. closed trading at $0.003, up 7.14%, on 330,000 volume with 9 trades. The stock’s average daily volume over the past 60 days is 2,758,453, and its 52-week low/high is $0.0025/$0.013.

Neah Power Systems, Inc. (NPWZ) is focused on the development of innovative, long-lasting, efficient and safe power solutions for military, transportation and portable electronics applications. The company applies its portfolio of patented technologies to maintain a competitive position in the fast-growing market for fuel cells and power generation devices.

At the core of Neah Power Systems' fuel cell business is three product lines, each in various degrees of progression and potential commercial partnerships: the patented and award winning, silicon-based Powerchip® technology; BuzzBar™ and BuzzCell™ micro fuel cells, which use patent pending low cost, differentiated technology; and Formira™, a reformer platform for direct on-site generation of hydrogen gas. Neah Power Systems' partnership agreement with Tectonica of Australia will allow for cross marketing of Tectonica's BANTAM® System and Neah Power Systems' Formira™ HOD technology in a wide range of geographic areas.

Neah Power Systems has 14 patents and eight patents pending. Prospective applications of these technologies include notebook, PCs, military radios, drones, and other computer, entertainment and communications products. The company's ideas and products received several industry awards, including: 2012 ZINO Green finalist, 2010 WTIA finalist, and 2010 Best of What's New™ Popular Science, Office of Naval Research Award, Red Herring Top 100 Innovators Winner, NIST Award and more.

At the helm of progressive market achievements and innovations is a management team and board of directors decorated with decades of relative expertise and knowledge. This team of individuals delivers a wealth of experience and hands-on development, which are complementary to Neah Power Systems' impressive intellectual property portfolio and fuel the company's increasing momentum in the competitive energy, fuel cell and technology sector. Disclaimer

Neah Power Systems, Inc. Company Blog

Neah Power Systems, Inc. News:

NEAH Power Systems and Black-I Robotics Team Up to Power the Robotics Industry

NEAH Power Systems, Inc. (NPWZ) CEO Featured in Exclusive QualityStocks Interview

NEAH Power Systems, Inc. (NPWZ) Announces Engagement of QualityStocks Investor Relations Services

Legacy Ventures International, Inc. (LGYV)

The QualityStocks Daily Newsletter would like to spotlight Legacy Ventures International, Inc. (LGYV). Today, Legacy Ventures International, Inc. closed trading at $1.35, up 3.05%, on 2,100 volume with 2 trades. The stock’s average daily volume over the past 60 days is 4,641, and its 52-week low/high is $0.01/$2.50.

Legacy Ventures International, Inc. (LGYV) is an investment company seeking out high-potential businesses with big ideas that can be scaled in order to promote hyper growth. The company fuels innovation and passion by providing the capital, oversight and connections that young businesses need to reach their full potential.

Legacy is led by a highly-qualified executive team with decades of relevant industry experience. Evan Clifford, the company's chief executive officer, has spent more than 15 years building and maintaining relationships with some of North America's most influential executives. Over the past decade, he has served as a lead advisor to a collection of companies and individuals striving for personal and professional success. Likewise, Rehan Saeed, Legacy's chief financial officer, has over a decade of experience in the banking industry during which he built and managed a real estate portfolio valued at $110 million.

The company's current brand portfolio is headlined by newly-acquired RM Fresh Brands, a servicer of food and beverage retailers and distributors around the globe. RM Fresh Brands takes a unique approach to brand partnerships by maintaining a clear focus on sustainable, category-changing consumables. This strategy has helped it build an extensive portfolio of highly-desirable brands – including Boxed Water, Aloe Gloe, Uncle Si's Iced Tea and Chef 5-Minute Meals.

Following the successful acquisition of RM Fresh Brands, Legacy is in a strong strategic position to move forward with its efforts to promote sustainable growth. The company will lean on the considerable experience of its management team as it looks to build on its recent progress while promoting maximized shareholder value. Disclaimer

Legacy Ventures International, Inc. Company Blog

Legacy Ventures International, Inc. News:

Legacy Ventures International, Inc. (LGYV) is “One to Watch”

Legacy Ventures Acquires RM Fresh Brands

Legacy Ventures Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Yea


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251